Bernstein Liebhard LLP is investigating whether certain directors and officers of Embecta Corp. breached their fiduciary duties to shareholders. The law firm aims to determine if Embecta's leadership acted in shareholders' best interests and if legal action is warranted. Current shareholders who purchased shares before November 25, 2025, are encouraged to contact the firm for a confidential consultation. This investigation could lead to legal remedies if breaches are confirmed.
President Donald Trump announced a temporary pause on the 50% tariffs scheduled to hit Canadian imports, following a trade deal agreement pending final documentation. The tariffs, set to affect about $20 billion in goods including vehicles, dairy, an...
Riot Platforms sold 9,665 bitcoin in the first half of 2026, including 4,300 BTC in Q2, to finance its pivot from bitcoin mining to AI infrastructure. Despite reducing its bitcoin treasury to 11,380 BTC, Riot is expanding its data center operations, ...
In Q2 2026, David Tepper's Appaloosa fund initiated a significant new position in CoreWeave, an AI cloud infrastructure company, while George Soros's fund held puts against the same stock but reduced their bearish exposure during the quarter. CoreWea...
Nuclear energy stocks like Oklo, Constellation Energy, and NuScale Power fell sharply due to concerns over AI-related capital expenditure and a spike in long-term Treasury yields to a 19-year high. AI companies reported lower-than-expected revenue fo...
Palvella is progressing its drug QTORIN, targeting microcystic lymphatic malformations and other skin diseases, supported by positive Phase 3 SELVA trial results. The company is leveraging a repeatable regulatory and commercial platform to expand QTO...
